sports | Business | Health | food | Technology | money |
Canada’s first homegrown vaccine for COVID-19 is showing promising antibody results in hundreds of participants in a Phase 2 trial and could be ready for a final authorization request this summer, the drugmaker says.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.